Melatonin for Prevention of Metabolic Side Effects of Olanzapine

NCT01593774 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Melatonin
DRUG: Placebo

Sponsor

Guilan University of Medical Sciences